Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
MGNI
|
David Day
CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct | 13,245 Reduced 2.64% |
$243,045
$18.35 p/Share
|
Feb 06
2025 |
|
S
|
Tomer Weingarten
President, CEO |
SELL
Open market or private sale
|
Direct | 10,178 Reduced 1.06% |
$243,763
$23.95 p/Share
|
Feb 06
2025 |
|
SCHW
|
Carolyn Schwab Pomerantz
Director |
SELL
Open market or private sale
|
Indirect | 24,000 Reduced 0.0% |
$1,984,800
$82.7 p/Share
|
Feb 06
2025 |
|
SFM
|
Jack Sinclair
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 2,915 Reduced 2.03% |
$491,294
$168.54 p/Share
|
Feb 06
2025 |
|
GMGI
|
Aleksandar Milovanovic |
BUY
Open market or private purchase
|
Direct | 20,000 Added 0.03% |
$37,000
$1.85 p/Share
|
Feb 06
2025 |
|
DMLP
|
Dorchester Minerals Operating LP |
BUY
Open market or private purchase
|
Direct | 335 Added 0.69% |
$10,405
$31.06 p/Share
|
Feb 06
2025 |
|
JCI
|
Daniel C Mcconeghy
VP Chief Accounting & Tax Ofcr |
SELL
Open market or private sale
|
Direct | 1,950 Reduced 7.29% |
$171,073
$87.73 p/Share
|
Feb 06
2025 |
|
TEM
|
Eric P Lefkofsky
CEO and Chairman |
SELL
Open market or private sale
|
Direct | 85,109 Reduced 1.56% |
$5,829,966
$68.5 p/Share
|
Feb 06
2025 |
|
TEM
|
Ryan M Bartolucci
Chief Accounting Officer |
SELL
Open market or private sale
|
Direct | 2,320 Reduced 4.19% |
$164,720
$71.0 p/Share
|
Feb 06
2025 |
|
JCI
|
John Donofrio
Exec VP & General Counsel |
SELL
Open market or private sale
|
Direct | 69,746 Reduced 70.96% |
$6,078,363
$87.15 p/Share
|
Feb 06
2025 |
|
ATI
|
Tina Killough Busch
SVP, CHRO |
SELL
Open market or private sale
|
Direct | 9,900 Reduced 27.58% |
$657,459
$66.41 p/Share
|
Feb 06
2025 |
|
JCI
|
George Oliver
Chairman & CEO |
SELL
Open market or private sale
|
Direct | 205,168 Reduced 14.0% |
$17,734,721
$86.44 p/Share
|
Feb 06
2025 |
|
INSM
|
Michael Alexander Smith
Chief Legal Officer |
SELL
Open market or private sale
|
Direct | 20,650 Reduced 17.61% |
$1,670,585
$80.9 p/Share
|
Feb 06
2025 |
|
INSM
|
Sara Bonstein
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 28,390 Reduced 15.44% |
$2,296,751
$80.9 p/Share
|
Feb 06
2025 |
|
INSM
|
John Drayton Wise
Chief Commercial Officer |
SELL
Open market or private sale
|
Direct | 7,910 Reduced 5.61% |
$639,919
$80.9 p/Share
|
Feb 06
2025 |
|
INSM
|
William Lewis
Chair and CEO |
SELL
Open market or private sale
|
Direct | 79,350 Reduced 14.88% |
$6,419,415
$80.9 p/Share
|
Feb 06
2025 |
|
INSM
|
Roger Adsett
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 45,605 Reduced 19.43% |
$3,689,444
$80.9 p/Share
|
Feb 06
2025 |
|
INSM
|
Orlov S Nicole Schaeffer
Chief People Strategy Officer |
SELL
Open market or private sale
|
Direct | 23,500 Reduced 16.28% |
$1,901,150
$80.9 p/Share
|
Feb 06
2025 |
|
INSM
|
Martina M.D. Flammer
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 33,055 Reduced 19.32% |
$2,674,149
$80.9 p/Share
|
Feb 06
2025 |
|
KD
|
Vineet Khurana
SVP & Global Controller |
SELL
Open market or private sale
|
Direct | 55,465 Reduced 55.83% |
$2,372,792
$42.78 p/Share
|
Feb 06
2025 |
|
RELY
|
Matthew B. Oppenheimer
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 14,583 Reduced 0.33% |
$372,449
$25.54 p/Share
|
Feb 06
2025 |
|
FRST
|
William Rand Cook |
BUY
Open market or private purchase
|
Direct | 2,242 Added 7.2% |
$24,998
$11.15 p/Share
|
Feb 06
2025 |
|
GFF
|
James W Sight
Director |
SELL
Open market or private sale
|
Direct | 1,360 Reduced 8.14% |
$110,160
$81.0 p/Share
|
Feb 06
2025 |
|
GFF
|
Cheryl L Turnbull
Director |
SELL
Open market or private sale
|
Direct | 3,000 Reduced 8.89% |
$242,400
$80.8 p/Share
|
Feb 06
2025 |
|
TTSH
|
Fund 1 Investments, LLC |
BUY
Open market or private purchase
|
Indirect | 5,000 Added 0.0% |
$36,600
$7.32 p/Share
|
Feb 06
2025 |
|
FLWS
|
Fund 1 Investments, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 64,500 Added 0.0% |
$526,965
$8.17 p/Share
|
Feb 06
2025 |
|
KD
|
Edward Sebold
General Counsel and Secretary |
SELL
Open market or private sale
|
Direct | 27,500 Reduced 17.15% |
$1,175,625
$42.75 p/Share
|
Feb 06
2025 |
|
SNOW
|
Benoit Dageville
President of Products |
SELL
Open market or private sale
|
Direct | 12,500 Reduced 20.76% |
$2,363,875
$189.11 p/Share
|
Feb 06
2025 |
|
TSCO
|
Melissa Kersey
EVP Chief HR Officer |
SELL
Open market or private sale
|
Direct | 9,300 Reduced 21.01% |
$494,387
$53.16 p/Share
|
Feb 06
2025 |
|
SPT
|
Justyn Russell Howard
Executive Chair |
SELL
Open market or private sale
|
Indirect | 40,000 Reduced 0.0% |
$1,311,600
$32.79 p/Share
|
Feb 06
2025 |
|
USB
|
Jodi L Richard
Vice Chair |
SELL
Open market or private sale
|
Direct | 30,000 Reduced 23.11% |
$1,427,700
$47.59 p/Share
|
Feb 06
2025 |
|
FRST
|
Susan B Williamson
EVP, Director of Reg Relations |
BUY
Open market or private purchase
|
Direct | 2,800 Added 25.01% |
$31,220
$11.15 p/Share
|
Feb 06
2025 |
|
EQR
|
Michael L Manelis
Executive Vice President & COO |
SELL
Open market or private sale
|
Direct | 9,487 Reduced 26.16% |
$683,728
$72.07 p/Share
|
Feb 06
2025 |
|
CLXT
|
Gerhard Prante
Director |
SELL
Open market or private sale
|
Direct | 1,150 Reduced 4.83% |
$2,932
$2.55 p/Share
|
Feb 06
2025 |
|
EWTX
|
Kevin Koch
President and CEO |
SELL
Open market or private sale
|
Direct | 900 Reduced 5.85% |
$28,017
$31.13 p/Share
|
Feb 06
2025 |
|
EWTX
|
Alan J Russell
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 1,200 Reduced 7.47% |
$36,156
$30.13 p/Share
|
Feb 06
2025 |
|
EQR
|
Ian Kaufman
Chief Accounting Officer |
SELL
Open market or private sale
|
Direct | 642 Reduced 2.45% |
$46,262
$72.06 p/Share
|
Feb 06
2025 |
|
EQR
|
Robert Garechana
EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 4,294 Reduced 23.33% |
$309,425
$72.06 p/Share
|
Feb 06
2025 |
|
OC
|
Nicolas Del Monaco
President, Insulation |
SELL
Open market or private sale
|
Direct | 1,750 Reduced 13.07% |
$321,947
$183.97 p/Share
|
Feb 06
2025 |
|
OC
|
Jose Mendez Andino
EVP, Chief R&D Officer |
SELL
Open market or private sale
|
Direct | 218 Reduced 1.57% |
$40,105
$183.97 p/Share
|
Feb 06
2025 |
|
EQR
|
Scott Fenster
EVP & General Counsel |
SELL
Open market or private sale
|
Direct | 5,340 Reduced 13.07% |
$384,800
$72.06 p/Share
|
Feb 06
2025 |
|
ATGE
|
Michael Betz
Pres. Walden University & CDO |
SELL
Open market or private sale
|
Direct | 3,500 Reduced 17.17% |
$379,995
$108.57 p/Share
|
Feb 06
2025 |
|
LC
|
Scott Sanborn
CEO |
SELL
Open market or private sale
|
Direct | 17,000 Reduced 1.3% |
$233,920
$13.76 p/Share
|
Feb 06
2025 |
|
TEAM
|
Scott Farquhar |
SELL
Open market or private sale
|
Indirect | 7,948 Reduced 0.0% |
$2,553,771
$321.31 p/Share
|
Feb 06
2025 |
|
TEAM
|
Michael Cannon Brookes
CEO, Co-Founder |
SELL
Open market or private sale
|
Indirect | 7,948 Reduced 0.0% |
$2,553,771
$321.31 p/Share
|
Feb 06
2025 |
|
EL
|
Paul J Fribourg
Director |
BUY
Open market or private purchase
|
Indirect | 44,000 Added 0.0% |
$2,883,320
$65.53 p/Share
|
Feb 06
2025 |
|
EQR
|
Catherine Carraway
EVP & CHRO |
SELL
Open market or private sale
|
Direct | 845 Reduced 5.79% |
$60,890
$72.06 p/Share
|
Feb 06
2025 |
|
MRK
|
Inge G Thulin
Director |
BUY
Open market or private purchase
|
Direct | 2,832 Added 49.13% |
$249,924
$88.25 p/Share
|
Feb 06
2025 |
|
EQR
|
Alexander Brackenridge
Executive Vice President & CIO |
SELL
Open market or private sale
|
Direct | 12,459 Reduced 13.12% |
$897,795
$72.06 p/Share
|
Feb 06
2025 |
|
RXRX
|
Christopher Gibson
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 1.55% |
$162,399
$8.12 p/Share
|
Feb 06
2025 |